1. Home
  2. ALT vs EFR Comparison

ALT vs EFR Comparison

Compare ALT & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • EFR
  • Stock Information
  • Founded
  • ALT 1997
  • EFR 2003
  • Country
  • ALT United States
  • EFR United States
  • Employees
  • ALT N/A
  • EFR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • EFR Trusts Except Educational Religious and Charitable
  • Sector
  • ALT Health Care
  • EFR Finance
  • Exchange
  • ALT Nasdaq
  • EFR Nasdaq
  • Market Cap
  • ALT 348.6M
  • EFR 342.8M
  • IPO Year
  • ALT N/A
  • EFR N/A
  • Fundamental
  • Price
  • ALT $4.00
  • EFR $11.36
  • Analyst Decision
  • ALT Strong Buy
  • EFR
  • Analyst Count
  • ALT 7
  • EFR 0
  • Target Price
  • ALT $16.50
  • EFR N/A
  • AVG Volume (30 Days)
  • ALT 2.7M
  • EFR 88.6K
  • Earning Date
  • ALT 11-07-2025
  • EFR 01-01-0001
  • Dividend Yield
  • ALT N/A
  • EFR 9.43%
  • EPS Growth
  • ALT N/A
  • EFR N/A
  • EPS
  • ALT N/A
  • EFR 1.69
  • Revenue
  • ALT $20,000.00
  • EFR N/A
  • Revenue This Year
  • ALT N/A
  • EFR N/A
  • Revenue Next Year
  • ALT N/A
  • EFR N/A
  • P/E Ratio
  • ALT N/A
  • EFR $7.74
  • Revenue Growth
  • ALT N/A
  • EFR N/A
  • 52 Week Low
  • ALT $2.90
  • EFR $10.95
  • 52 Week High
  • ALT $11.16
  • EFR $13.29
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.72
  • EFR 50.11
  • Support Level
  • ALT $3.83
  • EFR $11.26
  • Resistance Level
  • ALT $4.15
  • EFR $11.49
  • Average True Range (ATR)
  • ALT 0.17
  • EFR 0.10
  • MACD
  • ALT 0.00
  • EFR 0.02
  • Stochastic Oscillator
  • ALT 58.90
  • EFR 66.67

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

Share on Social Networks: